KARL STORZ Announces FDA Clearance for Rubina Lens for Open Surgery
Powerful technology lets surgeons incorporate NIR/ICG imaging into open procedures
KARL STORZ, a global leader in endoscopic and minimally invasive surgical technology, has received FDA clearance for the Rubina™ Lens exoscope for open surgery, broadening the company’s near-infrared (NIR) imaging ecosystem across open and minimally invasive procedures in the United States.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260610715509/en/ The Rubina™ Lens digital exoscope displays a magnified 4K image of the surgical field on a monitor. The ability to switch to NIR/ICG fluorescence imaging helps reveal information that cannot be seen with the naked eye.
The digital, camera‑based Rubina™ Lens exoscope displays a real‑time, magnified 4K image of the surgical field on a monitor. With the ability to switch into NIR imaging using indocyanine green (ICG), the Rubina™ Lens exoscope helps reveal important information that cannot be seen with the naked eye, supporting more informed decision‑making during open surgery.
